Chronic lymphocytic leukemia (CLL) accounts for the vast majority of cases of leukemia.
Patients of advanced age are more likely to develop the condition, which has a highly varied …

Hematopoietic stem cells (HSCs) produce all blood cells throughout the life of the organism.
However, the high self-renewal and longevity of HSCs predispose them to accumulate …

Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder characterized by a
specific expansion of mature B-cell clones. We hypothesized that the disease has a …

Objective: To determine the frequency of autoimmune cytopenias in chronic lymphocytic
leukemia. Methods: This cross sectional study was carried out at Department of Hematology …

Object. In this study, bioinformatics analysis of differentially expressed genes (DEGs) and
signaling pathway activities in different progression stages of chronic lymphocytic leukemia …

The aim of the present study was to investigate different biological prognostic markers to
identify high‑risk patients with chronic lymphocytic leukemia (CLL) with a higher tumor …

目的探讨低剂量FCR (氟达拉滨+ 环磷酰胺+ 利妥昔单抗) 方案治疗老年慢性淋巴细胞白血病(
chroniclymphocytic leukemia, CLL) 患者的价值. 方法回顾性分析86 例老年CLL …

One of the most common leukemia in the world is chronic lymphocytic leukemia (CLL). CLL,
as an incurable malignant disorder of B-lymphocytes. CD200, formerly known as OX-2, is a …

Introduction: Lymphocytosis is characterized by an elevation in the absolute lymphocyte
count (ALC) to over 4000 lymphocytes per microliter among adults. In lymphocytosis, the …

U veljači 2020. dopunjene su nacionalne smjernice za liječenje kronične limfocitne
leukemije (KLL) nakon odličnih rezultata kliničke studije CLL141. Prihvaćena je …